Bioceres Crop Solutions (NASDAQ:BIOX) Sees Large Volume Increase

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw strong trading volume on Wednesday . 172,302 shares were traded during mid-day trading, an increase of 150% from the previous session’s volume of 69,010 shares.The stock last traded at $8.57 and had previously closed at $8.48.

Wall Street Analysts Forecast Growth

BIOX has been the topic of a number of recent analyst reports. Oppenheimer dropped their price target on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating on the stock in a research report on Wednesday, September 11th. Lake Street Capital cut their target price on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Canaccord Genuity Group upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Roth Mkm decreased their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $13.63.

Bioceres Crop Solutions Stock Up 0.8 %

The company has a quick ratio of 0.83, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The stock has a 50-day simple moving average of $10.34 and a 200-day simple moving average of $11.33. The firm has a market capitalization of $536.91 million, a PE ratio of 848.00 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The firm had revenue of $124.30 million during the quarter, compared to the consensus estimate of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. Analysts forecast that Bioceres Crop Solutions Corp. will post 0.81 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Cape Investment Advisory Inc. purchased a new stake in Bioceres Crop Solutions during the 4th quarter worth about $33,000. Oppenheimer & Co. Inc. purchased a new position in Bioceres Crop Solutions during the first quarter valued at approximately $139,000. Lazard Asset Management LLC purchased a new stake in Bioceres Crop Solutions in the 1st quarter worth approximately $212,000. Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions in the second quarter worth $448,000. Finally, Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in shares of Bioceres Crop Solutions in the 2nd quarter valued at about $472,000. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.